Some studies with neoplasias show contradictory results in respect to anti-CD105 levels in the serum by ELISA [13], however, in leprosy, CD105 might be a marker of severity of the disease, as well as a predictive marker for reactional episodes. This evidence concerns the gene ENG and leprosy.